IXICO PHYOF Stock
IXICO Price Chart
IXICO PHYOF Financial and Trading Overview
IXICO stock price | 0.07 USD |
Previous Close | 0.3 USD |
Open | 0.3 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.3 - 0.3 USD |
52 Week Range | 0.003 - 0.77 USD |
Volume | 2.95K USD |
Avg. Volume | 201 USD |
Market Cap | 1.1B USD |
Beta (5Y Monthly) | 0.665517 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | -0.05 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PHYOF Valuation Measures
Enterprise Value | 9.99M USD |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 139.35954 |
Price/Book (mrq) | 1.2145749 |
Enterprise Value/Revenue | 1.261 |
Enterprise Value/EBITDA | 50.462 |
Trading Information
IXICO Stock Price History
Beta (5Y Monthly) | 0.665517 |
52-Week Change | -28.57% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.77 USD |
52 Week Low | 0.003 USD |
50-Day Moving Average | 0.04 USD |
200-Day Moving Average | 0.34 USD |
PHYOF Share Statistics
Avg. Volume (3 month) | 201 USD |
Avg. Daily Volume (10-Days) | 380 USD |
Shares Outstanding | 48.35M |
Float | 16.97M |
Short Ratio | N/A |
% Held by Insiders | 29.05% |
% Held by Institutions | 57.83% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | 1.75% |
Operating Margin (ttm) | -2.19% |
Gross Margin | 55.18% |
EBITDA Margin | 2.49% |
Management Effectiveness
Return on Assets (ttm) | -0.79% |
Return on Equity (ttm) | 1.18% |
Income Statement
Revenue (ttm) | 7.92M USD |
Revenue Per Share (ttm) | 0.16 USD |
Quarterly Revenue Growth (yoy) | -18.30% |
Gross Profit (ttm) | 5.24M USD |
EBITDA | 198K USD |
Net Income Avi to Common (ttm) | 139K USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 5.02M USD |
Total Cash Per Share (mrq) | 0.1 USD |
Total Debt (mrq) | 507K USD |
Total Debt/Equity (mrq) | 4.25 USD |
Current Ratio (mrq) | 5.01 |
Book Value Per Share (mrq) | 0.247 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.38M USD |
Levered Free Cash Flow (ttm) | -1202750 USD |
Profile of IXICO
Country | United States |
State | N/A |
City | London |
Address | Griffin Court |
ZIP | EC1A 9PN |
Phone | 44 20 3763 7499 |
Website | https://ixico.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 90 |
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. Further, the company engages in the data collection and analysis of neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.
Q&A For IXICO Stock
What is a current PHYOF stock price?
IXICO PHYOF stock price today per share is 0.07 USD.
How to purchase IXICO stock?
You can buy PHYOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IXICO?
The stock symbol or ticker of IXICO is PHYOF.
Which industry does the IXICO company belong to?
The IXICO industry is Biotechnology.
How many shares does IXICO have in circulation?
The max supply of IXICO shares is 92.67M.
What is IXICO Price to Earnings Ratio (PE Ratio)?
IXICO PE Ratio is now.
What was IXICO earnings per share over the trailing 12 months (TTM)?
IXICO EPS is -0.05 USD over the trailing 12 months.
Which sector does the IXICO company belong to?
The IXICO sector is Healthcare.